title: Is filgrastim as useless after peripheral blood stem cell transplantation for adults as it could be for children?
authors.forename: E
authors.initials: E
authors.lastname: Ojeda
authors.forename: J
authors.initials: J
authors.lastname: Garcia-Bustos
authors.forename: M J
authors.initials: MJ
authors.lastname: Agaudo
authors.forename: E
authors.initials: E
authors.lastname: Quevedo
authors.forename: R
authors.initials: R
authors.lastname: Arrieta
authors.forename: V
authors.initials: V
authors.lastname: Jimenez
authors.forename: M
authors.initials: M
authors.lastname: Canales
authors.forename: F
authors.initials: F
authors.lastname: Hernandez-Navarro
mesh_terms: D000328:Adult; D002648:Child; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D015203:Reproducibility of Results; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim